As Rocket awaits FDA review, J&J vet Chaudhuri joins as commercial lead

Gene therapy developer Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) named Sarbani Chaudhuri chief commercial and medical affairs officer. She was most recently a VP at the innovative medicines unit of Johnson & Johnson (NYSE:JNJ), with a focus on hematology; she has also held roles at AstraZeneca plc (LSE:AZN; NASDAQ:AZN), Pfizer Inc. (NYSE:PFE) and Novartis AG (SIX:NOVN; NYSE:NVS). Rocket is seeking approval of Kresladi marnetegragene autotemcel to treat severe leukocyte adhesion deficiency type I.

Cancer detection company Freenome Inc. named Aaron Elliott CEO. He was president and CEO of Realm Idx Inc., and previously held C-suite positions including CEO at what is now its Ambry Genetics Corp. unit...